Biolexis Completes Studies On Isoform-Specific Ampk Agonists
29 Oct 2024 //
PR NEWSWIRE
Biolexis Unveils Promising Preclinical Data For Oral Weight Loss Drug BLX-7006
12 Sep 2024 //
PR NEWSWIRE
Halia And Biolexis Identify Candidate For NLRP3-Driven Neuroinflammation
31 Jul 2024 //
PR NEWSWIRE
Biolexis to Present Two Groundbreaking Abstracts at Scientific Conference
21 Jun 2024 //
PR NEWSWIRE
Biolexis: Late-Breaker At AAI 2024 Annual Meeting
01 May 2024 //
PR NEWSWIRE